SJS Investment Consulting »

Aclaris Therapeutics shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2026-06-30 $539 102 5.29

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultr Fix Inc Etf (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Eli Lilly & Co. (LLY)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Apple (AAPL)
American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Hormel Foods Corporation (HRL)
American Centy Etf Tr Avan Tota Eq Etf (AVTM)
Dimensional Etf Trust Global Real Est (DFGR)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Us Sustainabilty (DFSU)

View all positions for SJS Investment Consulting

Top funds holding Aclaris Therapeutics

RA Capital Management
BML Capital Management
BlackRock
Deep Track Capital
Vivo Capital
Vanguard Capital Management
Frazier Life Sciences Management
Rock Springs Capital Management
Adage Capital Partners GP
Decheng Capital
Geode Capital Management
Morgan Stanley
Citadel Advisors
Braidwell
Balyasny Asset Management

View all funds holding Aclaris Therapeutics